Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forIdaho

Map
Idaho
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming
Idaho

Neglected diseases in Idaho

Chikungunya cases
Chikungunya cases
6
Dengue cases
Dengue cases
12
HIV diagnoses
HIV diagnoses
351
Malaria cases
Malaria cases
31
Tuberculosis cases
Tuberculosis cases
122
West Nile cases
West Nile cases
179
Zika cases
Zika cases
4
Idaho industry in global health R&D

Idaho industry in global health R&D

GSK
Location(s): Boise
Santa Cruz Biotechnology
Location(s): Sun Valley
Global health R&D at work in Idaho
Global health R&D at work in Idaho

Researchers at the University of Idaho are adapting the novel genome editing technology CRISPR to combat enteropathogenic E. coli, or EPEC—a diarrheal disease that kill hundreds of thousands of children worldwide each year. The researchers will test a two-part approach. First, they will engineer a bacteriophage, a virus that infects bacteria, to recognize and cut a DNA sequence found specifically in EPEC. Delivered via probiotics, this should kill the EPEC in the intestinal tract without affecting beneficial bacteria. Second, they will use custom-designed probiotics to deliver beneficial strains of E. coli with the ability to fight off the disease-causing strains. A key advantage of probiotics is that they are less disruptive to children's digestive tracts than antibiotics, which often kill both healthy and disease-causing bacteria.

Map
Select a new state
Footnotes
  • Methodology
  • Case study photo: PATH/Gabe Bienczycki
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In